基本没有在线的，有些都是几年前发布的消息
基本没有在线的，有些消息都是几年前发布的，根本沟通不了
药脉通Pro
Published by:
Hangzhou Yaomaitong Digital Technology Co
Description
药脉通Pro专注于药品、医疗器械等精准招商代理的APP，能够提升供需双方的连接效率，精准匹配资源，实现在线对接。
海量药械信息免费查询、发布。实时、高效、免费，让医疗销售更轻松！
【代理更高效】随时畅聊，闪电代理
【代理更安全】设有屏蔽功能，信息安全隐身
【好产品推荐】算法智能匹配，每日推荐好产品
医疗销售的新机会（药品器械耗材、医院药店诊所）尽在药脉通！
【意见反馈】
若您在使用中有任何问题及建议，欢迎前往药脉通Pro APP-我的-我的客服，我们将诚心接受您的意见。
海量药械信息免费查询、发布。实时、高效、免费，让医疗销售更轻松！
【代理更高效】随时畅聊，闪电代理
【代理更安全】设有屏蔽功能，信息安全隐身
【好产品推荐】算法智能匹配，每日推荐好产品
医疗销售的新机会（药品器械耗材、医院药店诊所）尽在药脉通！
【意见反馈】
若您在使用中有任何问题及建议，欢迎前往药脉通Pro APP-我的-我的客服，我们将诚心接受您的意见。
In-Apps
- 6通宝币
- 200.00 Rs
- 38通宝币
- 1,300.00 Rs
- 298通宝币
- 12,900.00 Rs
- 498通宝币
- 19,900.00 Rs
Screenshots
药脉通Pro FAQ
-
Is 药脉通Pro free?
Yes, 药脉通Pro is free to download, however it contains in-app purchases or subscription offerings.
-
Is 药脉通Pro legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 药脉通Pro cost?
药脉通Pro has several in-app purchases/subscriptions, the average in-app price is 8,575.00 Rs.
-
What is 药脉通Pro revenue?
To get estimated revenue of 药脉通Pro app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Pakistan yet.
Ratings History
药脉通Pro Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
Keywords
药脉通Pro Competitors
药脉通Pro Installs
Last 30 days
药脉通Pro Revenue
Last 30 days药脉通Pro Revenue and Downloads
Gain valuable insights into 药脉通Pro performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Languages
- English, Chinese
- Recent release
- 1.9.3 (1 month ago )
- Released on
- Nov 4, 2021 (3 years ago )
- Also available in
- China, Malaysia, Vietnam, United States, Taiwan, Thailand, Singapore, Pakistan, Philippines, New Zealand, Australia, Kazakhstan, South Korea, Japan, Indonesia, Hong Kong SAR China, Canada
- Last Updated
- 3 days ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.